Evaluating Sepsis during Continuous Dialysis: Are Biomarkers Still Valid?

Publisher： Karger

E-ISSN： 1421-9735|38|2|104-105

ISSN： 0253-5068

Source： Blood Purification, Vol.38, Iss.2, 2014-10, pp. : 104-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Viral Hepatitis Infection Should Be Considered for Evaluating Uremic Pruritus in Continuous Ambulatory Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 16, Iss. 3, 1998-07 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

Continuous-Flow Peritoneal Dialysis

By  

Blood Purification, Vol. 18, Iss. 4, 2000-08 ,pp. : 361-365

Karger

Access to resources Recommend Favorite

The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 4-5, 2013-07 ,pp. : 252-258

Karger

Access to resources Recommend Favorite

Trends and Outcomes of Severe Sepsis in Patients on Maintenance Dialysis

By  

American Journal of Nephrology, Vol. 43, Iss. 2, 2016-03 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Biomarkers of Inflammation during Continuous Renal Replacement Therapy: Sensors, Players, or Targets? A Reply to the Letter by Villa et al.

By  

Blood Purification, Vol. 38, Iss. 2, 2014-10 ,pp. : 102-103

Karger

Access to resources Recommend Favorite